Maze Therapeutics to Present Additional Data Highlighting the Advancement of MZE829 and MZE782 Programs at ASN Kidney Week Life Science Investing
Tenax Therapeutics to Host Virtual KOL Call to Discuss TNX-103 for the Treatment of PH-HFpEF Life Science Investing
C4 Therapeutics Reports Third Quarter 2025 Financial Results and Recent Business Highlights Life Science Investing
Avenue Therapeutics Announces Acquisition of Subsidiary Baergic Bio by Axsome Therapeutics Life Science Investing
Axsome Therapeutics Acquires Subtype Selective GABA-A Receptor Positive Allosteric Modulator AZD7325 for the Treatment of Epilepsy Life Science Investing
Aclaris Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update Life Science Investing
Yunqi Capital Applauds STAAR Surgical's Strong Third Quarter Results and Reiterates That the Proposed Sale to Alcon Should Be Terminated Life Science Investing
Defence Announces Successful Presentation at the World ADC Conference in San Diego and Plans to Expand Evaluation of Accum in Commercial and Pipeline ADCs Life Science Investing
Medtronic to announce financial results for its second quarter of fiscal year 2026 Medical Device Investing
